Ingenia Therapeutics Inc. (KOSDAQ:950260)
18,470
+540 (3.01%)
At close: Sep 18, 2026
| Market Cap | 913.24B |
| Revenue (ttm) | 7.42B |
| Net Income | -22.38B |
| EPS | -807.42 |
| Shares Out | 49.44M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,773,975 |
| Open | 18,400 |
| Previous Close | 17,930 |
| Day's Range | 17,260 - 20,400 |
| 52-Week Range | 9,900 - 21,100 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 19, 2026 |